The Effects of Remdesivir on Mortality, Ventilation in Patients With COVID-19
Final evidence from the WHO Solidarity clinical trials shows that remdesivir has only a slight protective effect and only among certain patients with COVID-19.
Final evidence from the WHO Solidarity clinical trials shows that remdesivir has only a slight protective effect and only among certain patients with COVID-19.
Researchers assessed the frequency and severity of cognitive impairments over time and specifically 1 year after hospitalization in patients who contracted COVID-19.
In the early pandemic period, there was a decrease in seizure-related ED visits, which almost returned to prepandemic levels by the end of 2020.
Inappropriate antibiotic prescriptions are common among children with common infections treated in an outpatient setting.
In pregnant women with COVID-19, how does the severity and progression of disease affect cytokine profiles, especially towards the end of pregnancy?
Incident conditions that may be attributable to COVID-19 are common among adult COVID-19 survivors, according to recent study findings.
Extreme heat was associated with higher all-cause mortality from 2008 to 2017, according to a study published online.
A meta-analysis assessed whether non-steroidal anti-inflammatory drugs were associated with adverse outcomes among patients with COVID-19.
A study was conducted to determine the incidence of myopericarditis following COVID-19 vaccination compared with non-COVID-19 vaccination.
Following COVID-19 vaccination, there is an inverse correlation between anti-SARS-CoV-2-specific antibody levels and body weight.